Table 2.
Effect of age, ethnicity and personal characteristics on marker concentrations. The reference group is women under age 45. Age-related effects on ln(marker levels) are presented in the top half of the table. The bottom half presents the effects of other covariates in terms of percent change of marker levels. The marker value expected for an individual woman can be calculated using this table using instructions in the table footnote. Sample size refers to blood draws not number of women.
| Analysis | Covariate | Sample Size |
CA125 | HE4 | ROMA | |||
|---|---|---|---|---|---|---|---|---|
| Age-related effects on ln marker concentrations.* |
Coeff. | p-val. | Coeff. | p-val | Effect (log scale) |
p-val. | ||
| Intercept | Age < 45 (Reference) | 370 | 2.39859 | <0.001 | 2.99346 | <0.0005 | −4.72542 | <0.0005 |
| 45 ≤ age < 55 | 635 | 1.92218 | 0.007 | 0.25002 | 0.412 | −6.25026 | <0.0005 | |
| Age ≥ 55 | 775 | −0.35088 | 0.365 | −0.98948 | <0.0005 | 0.21848 | 0.583 | |
| trends | Age < 45 (Reference) | 370 | 0.00524 | 0.490 | 0.00820 | 0.013 | 0.01985 | 0.012 |
| 45 ≤ age < 55 | 635 | −0.04155 | 0.006 | −0.00551 | 0.398 | 0.13377 | <0.0005 | |
| age > 55 | 775 | −0.00224 | 0.797 | 0.01579 | <0.0005 | 0.00730 | 0.420 | |
|
Covariate effects on percent change of marker concentrations. |
% Change |
p-val. | % Change |
p-val. | % Change | p-val. | ||
| Age Adjust ed Effects |
Parous | 1186 | 4.0% | 0.355 | 0.4% | 0.867 | −0.004 | 0.935 |
| Non-White Race | 159 | 6.3% | 0.371 | 3.6% | 0.357 | 0.126 | 0.122 | |
| Black | 18 | −26.6% | 0.008 | −3.3% | 0.718 | −0.203 | 0.329 | |
| Asian | 42 | 20.4% | 0.112 | 7.7% | 0.474 | 0.317 | 0.142 | |
| Other | 99 | 7.5% | 0.417 | 2.9% | 0.454 | 0.094 | 0.200 | |
| Hispanic | 66 | 19.10% | 0.097 | 1.80% | 0.683 | 0.091 | 0.388 | |
| Ashkenazi Jewish | 325 | −7.4% | 0.163 | 0.9% | 0.702 | −0.011 | 0.850 | |
| Prior Tubal Ligation | 253 | 0.4% | 0.935 | −0.3% | 0.928 | −0.015 | 0.79 | |
| Current Smoker | 58 | 0.3% | 0.977 | 21.0% | 0.007 | 0.276 | 0.019 | |
| Current OC use | 91 | −13.0% | 0.100 | −1.8% | 0.632 | −0.115 | 0.225 | |
| Discontinuous OC | 48 | −5.4% | 0.641 | 2.4% | 0.649 | 0.04 | 0.766 | |
| Continuous OC | 43 | −18.9% | 0.041 | −5.8% | 0.217 | −0.265 | 0.012 | |
| Personal History of BC | 584 | −3.0% | 0.497 | 3.9% | 0.105 | 0.046 | 0.335 | |
To approximate the marker value expected for a woman of a specific age, first approximate the baseline LN marker level for the woman’s age as follows. Add the intercept terms (reference group plus the term from the age appropriate category) to the age multiplied by the age-related trend (reference group trend + age appropriate category trend). For example, baseline LN CA 125 level for a woman of age 50 will equal Y=(2.39859+1.92218)+ 50*(0.00524−0.04155) = 2.50, or 12.23 U/ml on the raw scale. To adjust the level on the raw scale for covariates, increase or decrease the calculated raw scale using the approximated effect size for that covariate. For example, a woman of age 50 who is of Black ethnicity will be expected to have CA 125 levels 26.6% lower, or 3.25 U/ml lower.
- ln(marker level) ~ intercept + age + I(45 < age < 55) + age * I(45 < age < 55) + I(age > 55) + age * I(age > 55)
Where indicator variables “I(…)” are set to 1 when the condition is met and 0 otherwise. Together, the intercept (e.g. “I(45 < age < 55)”) and trend (e.g. “age * I(45 < age < 55)”) terms allow for independent linear trends to be estimated within each age range.